Crew Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Crew Capital Management's BMY Position: Q3 2026 in Review
Crew Capital Management increased its Bristol-Myers Squibb (BMY) stake by 5.7% in Q3 2026, buying an estimated $60.9K and bringing the position to 17,871 shares worth $1.12M. The position accounts for 0.59% of the portfolio, ranked #53.
Crew Capital Management first reported a position in BMY in Q1 2021 and has held it in 14 quarters since. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Crew Capital Management held 17,871 shares of Bristol-Myers Squibb worth $1.12M as of Q3 2026.
- Crew Capital Management bought 964 Bristol-Myers Squibb shares in Q3 2026, an estimated $60.9K.
- Bristol-Myers Squibb made up 0.59% of Crew Capital Management's portfolio in Q3 2026, its #53 holding.
- Crew Capital Management first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 14 quarters since.
- 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Crew Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.